
News|Articles|June 12, 2026
How PBMs are tackling behavioral health
Author(s)Denise Myshko
Fact checked by: Cheney Gazzam Baltz
Demand for behavioral healthcare has surged, increasing costs for health plans and employers as millions of Americans deal with mental illness, substance use disorders and access challenges.
Advertisement
Advertisement
The COVID-19 pandemic exposed the cracks in America’s mental and behavioral healthcare system. At the height of the pandemic, the rates of depression and anxiety worldwide had increased by 25%, according to the World Health Organization, and 90% of adults in the U.S. believed the country was facing a mental health crisis, according to results of a
Related to this article

Federal HIV guidelines add Bixlenvo as a switch option, back statins for adults 40 to 75 and urge clinicians to challenge payer barriers to antiretroviral therapy (ART).

Sempre Health CEO Anurati Mathur says affordability dollars should reach patients on every fill, and reversed claims show plans when they don’t.

Based on her findings, Mathur shared members in a UPMC affordability program were more adherent to heart drugs, with fewer ER visits and no significant rise in total cost of care.

COPD patients who saw a care navigator had a 20% readmission rate vs. 35% for those who didn’t, in a quality improvement project at St. Joseph's Hospital in Tampa, Florida, according to research presented at CHEST 2026 meeting last week in Phoenix..

A standardized discharge checklist and care coordination cut 30-day COPD readmissions from 27.9% to 18.2%, according to research presented at CHEST 2026.

A Cencora analysis of 32 pre-approval products found more than 60% of payer engagement with PIE resources came more than 90 days after posting.

AMCP leaders say PBM reform, new drug pricing models and AI will shape this week’s Nexus meeting in San Diego.
Advertisement
Advertisement

